Ticker Launch
Sign inTry it free

SPAC · Merger completed

Mana Capital Acquisition Corp.

Business combination with Cardio Diagnostics, Inc.

Mana Capital Acquisition Corp. is a blank-check company (SPAC) that raised $62M in its initial public offering on Nov 24, 2021, listing on Nasdaq Global Market. It completed its business combination with Cardio Diagnostics, Inc. on Oct 25, 2022; the combined company is Cardio Diagnostics Holdings, Inc. (CDIO). Becker & Poliakoff advised the SPAC and Blank Rome advised the underwriters on the IPO.

Cardio Diagnostics is a biotechnology company working to make cardiovascular disease prevention and early detection more accessible, personalized and precise. It is developing and commercializing a proprietary AI-driven Integrated Genetic-Epigenetic Engine for cardiovascular disease.

Status
Merger completed
IPO date
Nov 24, 2021
IPO size
$62M
IPO exchange
Nasdaq Global Market
Target
Cardio Diagnostics, Inc. (Legacy Cardio)
Announced
May 31, 2022
Closed
Oct 25, 2022
Combined company
Cardio Diagnostics Holdings, Inc. (CDIO)
SPAC counsel (IPO)
Becker & Poliakoff
Underwriters' counsel (IPO)
Blank Rome

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2022